Chung-Wai Shiau

USPTO Granted Patents = 9 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

6 out of 1,198

National Yang Ming Chiao Tung University

patents

5 out of 1,721

National Taiwan University

4. 3 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11925650 - Antibacterial chemical compound, its manufacturing method and its use thereof (2024-03-12),

2. 10993923 - Method for ameliorating fibrosis using 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea (2021-05-04),

3. 10800732 - Substituted malonamides and their use as antibacterial drugs (2020-10-13),

4. 10793527 - Adenosine monophosphate-activated protein kinase agonist (2020-10-06),

5. 10745346 - Agonists of protein tyrosine phosphatase SHP-1 (2020-08-18),

6. 10189795 - Aryl amine substituted quinoxaline used as anticancer drugs (2019-01-29),

7. 9394261 - Aryl amine substituted pyrimidine and quinazoline and their use as anticancer drugs (2016-07-19),

8. 9216950 - Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same (2015-12-22),

9. 9090617 - Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same (2015-07-28),

Title: The Innovative Contributions of Chung-Wai Shiau in the Field of Antibacterial and Fibrotic Disease Treatments

Introduction

Chung-Wai Shiau is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to the fields of antibacterial treatments and fibrotic disease therapies. With a remarkable portfolio that includes nine patents, Shiau has made strides in developing innovative solutions that address pressing health challenges.

Latest Patents

Shiau's latest patents include a groundbreaking antibacterial chemical compound whose manufacturing method and applications are designed to combat infectious diseases, such as gastroenteritis and invasive non-typhoidal Salmonellosis. This invention provides a new therapeutic option for patients suffering from infections caused by antibiotic-resistant bacteria. Another notable patent from Shiau is a method for ameliorating fibrosis using a specific compound known as 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea. This invention focuses on treating fibrotic diseases such as skin sclerosis, cardiac fibrosis, and various organ-specific fibroses, showcasing his commitment to advancing medical therapeutics.

Career Highlights

Chung-Wai Shiau has been affiliated with prestigious institutions, including National Yang Ming Chiao Tung University and National Taiwan University. His role in these institutions has allowed him to not only further his research but also contribute to the academic and practical applications of his inventions. Through his work, he has established a strong foundation in research that addresses real-world health issues.

Collaborations

Throughout his career, Shiau has collaborated with esteemed colleagues, including Kuen-Feng Chen and Hao-Chieh Chiu. These collaborations have fostered an environment of innovation and creativity, allowing for the exchange of ideas that can lead to the development of new technologies and treatments.

Conclusion

Chung-Wai Shiau's contributions to the fields of antibacterial and fibrotic disease therapies have positioned him as an influential inventor. His patents not only demonstrate his inventive spirit but also his dedication to improving public health through innovative solutions. As he continues to advance his research, Shiau's work will likely inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.